Therapeutic implications of autoimmune vitiligo T cells
- 31 August 2006
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 5 (7) , 486-492
- https://doi.org/10.1016/j.autrev.2006.03.012
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2 restricted MART-1 T-cell receptor: a phase I trial in metastatic melanoma.Clinical Cancer Research, 2006
- Imbalance of regulatory T cells in human autoimmune diseasesImmunology, 2006
- Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With AutologousGM-CSF–Transduced Tumor Cells in Metastatic Melanoma PatientsJournal of Clinical Oncology, 2005
- Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligoEuropean Journal of Immunology, 2005
- Clinical profiles of vitiligo in China: an analysis of 3742 patientsClinical and Experimental Dermatology, 2005
- 4-Tertiary Butyl Phenol Exposure Sensitizes Human Melanocytes to Dendritic Cell-Mediated Killing: Relevance to VitiligoJournal of Investigative Dermatology, 2005
- What patients with vitiligo believe about their conditionInternational Journal of Dermatology, 2004
- Late onset vitiligo: A study of 182 patientsInternational Journal of Dermatology, 2004
- A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligoTrends in Immunology, 2001
- Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligoBritish Journal of Dermatology, 2000